Compare BNTX & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTX | LH |
|---|---|---|
| Founded | 2008 | 1971 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 21.2B |
| IPO Year | 2019 | N/A |
| Metric | BNTX | LH |
|---|---|---|
| Price | $98.56 | $254.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 12 |
| Target Price | $137.40 | ★ $301.33 |
| AVG Volume (30 Days) | ★ 1.1M | 592.3K |
| Earning Date | 11-03-2025 | 02-05-2026 |
| Dividend Yield | N/A | ★ 1.13% |
| EPS Growth | N/A | ★ 98.36 |
| EPS | N/A | ★ 10.19 |
| Revenue | $3,698,814,972.00 | ★ $13,765,300,000.00 |
| Revenue This Year | $2.03 | $10.80 |
| Revenue Next Year | N/A | $4.43 |
| P/E Ratio | ★ N/A | $25.00 |
| Revenue Growth | 3.70 | ★ 8.28 |
| 52 Week Low | $81.20 | $209.38 |
| 52 Week High | $126.77 | $293.72 |
| Indicator | BNTX | LH |
|---|---|---|
| Relative Strength Index (RSI) | 56.16 | 46.39 |
| Support Level | $95.85 | $245.00 |
| Resistance Level | $101.48 | $261.73 |
| Average True Range (ATR) | 1.81 | 4.71 |
| MACD | 0.89 | 0.46 |
| Stochastic Oscillator | 70.40 | 58.13 |
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.